pubmed.ncbi.nlm.nih.gov

Psychedelic Psychiatry's Brave New World - PubMed

  • ️Wed Jan 01 2020

. 2020 Apr 2;181(1):24-28.

doi: 10.1016/j.cell.2020.03.020.

Affiliations

Free article

Psychedelic Psychiatry's Brave New World

David Nutt et al. Cell. 2020.

Free article

Abstract

After a legally mandated, decades-long global arrest of research on psychedelic drugs, investigation of psychedelics in the context of psychiatric disorders is yielding exciting results. Outcomes of neuroscience and clinical research into 5-Hydroxytryptamine 2A (5-HT2A) receptor agonists, such as psilocybin, show promise for addressing a range of serious disorders, including depression and addiction.

Copyright © 2020 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources